您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:中生北控生物科技年报2024 - 发现报告

中生北控生物科技年报2024

2025-04-30港股财报善***
AI智能总结
查看更多
中生北控生物科技年报2024

GEM GEMGEMGEM GEMGEMGEM GEMGEM(1)(2) 3567101939474853575859616365128 27 1866 http://www.zhongsheng.com.cn H 1617 CPA, CPA (U.S.) CPA, CFA H GEM8247H64,286,143HH1.00 •2.6319.0%•5,6901,920• (In Vitro Diagnostics, IVD)IVD IVD IVDIVDPOCT IVD IVDSinoCyte 3,340AutoProSample A960 & BioCyte9r-GCANA116biosino (a) IVD 30%-40% IVD (c) IVD IVD IVDSinoCyte (b) 10%-15% (c) 2.6312.8919.0% 1.0841.27414.9%41.2%44.1% 5,6205,9004.7% 5,0405,1502.1% 3,3403,5806.7% 93064045.3% 650701,30060 5,6901,920 4,2501,160 37.1711,0005,000 IVDIVD IVD IVD POCT IVD 70 1,9802202,8905,0001,8201,0001,000 70480 4995371.039,900 GEMC1 D.2.5 D.2.5(i)GEM(ii) GEM5.02D5.02D (a)(b)(c)(d)(e) (i)(ii)(iii)(iv) (a)(b)(c)(d)(e)(f) GEM5.09 96% 4/55/54/55/55/55/55/55/55/52/2 2/22/22/22/22/22/21/22/21/21/1 GEM5.485.67GEM ––– 2/22/22/20/0 E.1.2(c)(ii) 1,000,0001,000,0012,000,000 89 (i)(ii)(iii)(iv)(v) –––––– 3/33/32/33/31/1 (i)(ii) (i) (ii)GEM (i)(a)(b)(c)GEM17.50(2) (ii) GEM17.10452:48 GEM 1.2.3.4. 3/33/33/32/2 (i)(ii)(iii)(iv) GEM 15 1,277,000 5456 GEMC.1.4 (i)GEM(ii) (i)16.9918.69GEM(ii)5.055.56GEM(iii)1.611.77GEM20.74GEM(i)(ii) 1. 2.IVD30500 3. 4.IVDISO90012008ISO134852003 5. 6. 7. 8.1 GEM (zhongsheng.com.cn) 21GEM 3% 1866(852) 2108 4001 1 5 57127 128 12 26 27 53,196,00014,433,00035 7,08027%2,1308%4,42030%1,98014%5% GEM5.09 89 4852 32 571XV352GEM5.465.68 352GEM5.465.68 GEM XV23336 XV23336 GEM11.23(7)25%GEMH HH25% D.2.5 D.2.5(i)GEM(ii) GEM 32 GEM17.2217.24 GEM17.2217.24 GEM17.50A(1) 63EMBA 61 5020 51 61EMBA 59Howard Hughes Medical Institute 61 44 61(College of Pharmacy, Health Science Center, University of New Mexico)EPR(National EPR Center, Department of Radiology at Dartmouth MedicalSchool) 5320RHEIPharmaceuticals,Inc.Columbus Growth, LLC 40 35 6130 60 543923716191089666 37392 57127 263,069,000 2.45 •••• • • P08363 10 18192021 1. 27 **2,0007,29082.99%1,650 1. 2. 2.1. (a)(b)(c) 2.1. 56,889,0007,490,00068,213,000143,665,000100,000,00020,000,000 2.2. 161177 2.3. 1028 123344 21197971918 1234 18 187181818 2.4. 20% 5 2.4. 2.4. 2.4. 5 3.17%4.75%10.00%8.60%19.40%19.00%32.33%19.00%24.25% 2.4. 30 2.4. 40215 2.4. (b)(c)12 15 2.4. 32 2.4. ••(a)(b) 2.4. 1212 30 90 –12–– 2.4. 2.4. 2.4. •• •• 2.4. 2.4. (a)(b) 2.4. 3. 50%90% 19 3. 1,006,000194,715,000151,601,00025 2.41,068,0006,088,000 4. 91% 10%32,832,00011% 5. 5. 6. 6. (i)7,422,0008,115,00018,609,00020,890,0001,794,0001,563,000(ii)887,0003,256,00019,854,00020,498,000236,000479,000(iii)879,000781,00030,576,00028,178,000639,000695,000(iv)1,872,0001,926,00033,891,00029,652,000220,000272,000(v)3,137,0002,548,0002,529,0002,405,00091,00091,000477,00017,00040,00035,000 7. 8. 383(1)(a)(b)(c)(f)2 (a) 1 1 8. 1 8. (b) 4 7 9. 8 1,000,000 10. 25% 15% 25 10. 62,0001,852,000 11. 144,707,176144,707,176 11. 12. 1,9802,1102202302,8906,5205,000 6,800,0005,000,0009%1,700,0003,300,000 12. 3,200,0003,000,0006.2%1,200,0001,500,000 3,600,000 13. 1,8202,0701,0001,0001,000 13. 1,820 14. 4021512 (a) 14. 15. 12.7%750 16. 16. 50%20 16. 1,008,000 17. 17. 18. 19. 19. 346712122 1122 6 19. (a)51%163,200,00021,100,000184,300,000 70%184,300,000 (i)184,300,000 (ii) 138,500,000 20. 184,300,000 10,000,0008,500,000182,800,000 (1)50%145,000,000(2)37,800,000 50%3,300,000 3,300,000 71,000,00071,000,000 (b)1,500,000 21. 56,025,44754,225,000 22. 346712122 3090 23. (a)(b)21.64%4,500,0004,000,000 24. 24. 1213 25. 25. 10 194,715,000151,601,000 26. 80,421,03380,421,033164,286,14364,286,143H1 27. 6162 28. 28. 29. (b) 30. 31. 32. (a) 32. (i)23(b)(ii)2008%51%(iii)19%20(b) 33. 33. 34. 196,528,000711,00019 34. 34. 35. 35. 36.